SBTX

Silverback Therapeutics, Inc.

We can't put a fair value on SBTX right now. We haven't analysed this company yet.

Follow SBTX

Track it on your watchlist and see the full analysis. Free.

Superinvestors

1 of the investors we track holds SBTX. In Q1 2026, 1 added. Who we track

Daniel Loeb

Third Point · as of Q2 2026

$8.0M

1,000,000 shares

Moves in Q1 2026

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. How the Payback Price works